Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Elisa Coviello"'
Autor:
Massimiliano Gambella, Simona Carlomagno, Rosa Mangerini, Nicoletta Colombo, Alessia Parodi, Chiara Ghiggi, Livia Giannoni, Elisa Coviello, Chiara Setti, Silvia Luchetti, Alberto Serio, Antonella Laudisi, Monica Passannante, Alessandra Bo, Elisabetta Tedone, Simona Sivori, Emanuele Angelucci, Anna Maria Raiola
Publikováno v:
eJHaem, Vol 5, Iss 2, Pp 360-368 (2024)
Abstract CAR− CD4+ T cell lymphopenia is an emerging issue following CAR‐T cell therapy. We analyzed the determinants of CD4+ T cell recovery and a possible association with survival in 31 consecutive patients treated with commercial CAR‐T for
Externí odkaz:
https://doaj.org/article/bf6c9dbea539468fabc29f1c813bcaaf
Autor:
Francesco Merli, Carlo Visco, Annarita Conconi, Daniele Vallisa, Elettra Ortu La Barbera, Sara Galimberti, Roberto Mina, Marianna Sassone, Anna Guidetti, Adriano Venditti, Alessandro Corso, Francesco Marchesi, Pellegrino Musto, Agostino Tafuri, Valentina Bonuomo, Filippo Gherlinzoni, Francesco Lanza, Monia Marchetti, Safaa M. Ramadan, Marco Salvini, Massimo Massaia, Elisa Coviello, Alessandro Busca, Luigi Petrucci, Daniele Armiento, Mauro Turrini, Alessandra Romano, Chiara Cattaneo, Francesco Passamonti, Matteo G. Della Porta, Anna Candoni, Luigi Rigacci, Luca Arcaini, Livio Trentin, Valeria Cardinali, Maria Chiara Tisi, Carmine Selleri, Carlo Gambacorti-Passerini, Andrés J.M. Ferreri, Patrizia Tosi, Riccardo Bruna, Mauro Krampera, Antonio Cuneo, Nicola Stefano Fracchiolla, Daniela Cilloni, Lorenza Bertù, Paolo Corradini, Annamaria Scattolin, Roberto Cairoli, Giuseppe Visani, Domenico Penna, Marco Ladetto, Antonello Pinto, Michele Cavo, Monica Bocchia, Sofia Pilerci, Luigi Marcheselli
Publikováno v:
Blood Advances
Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c511abaff8f6767b1c8847f0db05744
http://hdl.handle.net/11568/1132840
http://hdl.handle.net/11568/1132840
Autor:
Michele Merli, Isacco Ferrarini, Francesco Merli, Alessandro Busca, Roberto Mina, Brunangelo Falini, Riccardo Bruna, Roberto Cairoli, Monia Marchetti, Alessandra Romano, Michele Cavo, Luca Arcaini, Livio Trentin, Chiara Cattaneo, Enrico Derenzini, Nicola Stefano Fracchiolla, Francesco Marchesi, Annamaria Scattolin, Atto Billio, Monica Bocchia, Massimo Massaia, Carlo Gambacorti‐Passerini, Francesca Romana Mauro, Massimo Gentile, Sara Mohamed, Matteo Giovanni Della Porta, Elisa Coviello, Daniela Cilloni, Giuseppe Visani, Augusto Bramante Federici, Maria Chiara Tisi, Laura Cudillo, Sara Galimberti, Filippo Gherlinzoni, Livio Pagano, Anna Guidetti, Lorenza Bertù, Paolo Corradini, Francesco Passamonti, Carlo Visco
COVID-19, the disease caused by SARS-CoV-2, is still afflicting thousands of people across the globe. Few studies on COVID-19 in chronic lymphocytic leukemia (CLL) are available. Here, we analyzed data from the CLL cohort of the Italian Hematology Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e896a46defa346fed22a387f3cd575e
https://hdl.handle.net/20.500.11769/542050
https://hdl.handle.net/20.500.11769/542050
Autor:
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, Livio Pagano, Anna Guidetti, Pellegrino Musto, Riccardo Bruna, Monica Bocchia, Andrea Visentin, Mauro Turrini, Alessandra Tucci, Sofia Pilerci, Luana Fianchi, Marco Salvini, Sara Galimberti, Elisa Coviello, Carmine Selleri, Mario Luppi, Enrico Crea, Paola Fazi, Francesco Passamonti, Paolo Corradini
COVID-19 continues to be a relevant issue among patients with haematological malignancies (HM). Vaccines are frequently not effective in subjects on active treatment. In this multicentre retrospective study of Gruppo Italiano Malattie EMatologiche de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf3393798b0a4affd35fc67a5881c78
http://hdl.handle.net/11577/3452977
http://hdl.handle.net/11577/3452977
Autor:
Filippo Antonio Canale, Maurizio Miglino, Lorenzo Manconi, Marco Gobbi, Paola Minetto, Michele Cea, Livia Giannoni, Fabio Guolo, Elisa Coviello, Filippo Ballerini, Riccardo Marcolin, Marino Clavio, Roberto M. Lemoli, Antonia Cagnetta
Publikováno v:
Leukemia & Lymphoma. 61:84-90
Cisplatin-containing salvage regimens followed by autologous hematopoietic stem cell (HSC) transplantation are the current standard of care for relapsed or refractory (R/R) lymphomas. We retrospectively analyzed efficacy and stem cell mobilizing acti
Autor:
Marino Clavio, Marco Gobbi, Paola Minetto, Fabio Guolo, Massimo Zucchetti, Roberto M. Lemoli, Maurizio Miglino, Maurizio D'Incalci, Cristina Matteo, Filippo Ballerini, Elisa Coviello, Mariella Ferrari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258c3d345890cc1569b1b3bf3449cd7b
http://hdl.handle.net/11567/944232
http://hdl.handle.net/11567/944232
Autor:
Filippo Ballerini, Jean Louis Ravetti, Maurizio Miglino, Lorenzo Manconi, Michela Frello, Filippo Antonio Canale, Paola Minetto, Maria Carla De Luigi, Fabio Guolo, Daniela Fenoglio, Silvia Luchetti, Emanuela Marcenaro, Marco Gobbi, Alberto Serio, M.R. Ruzzenenti, Paolo Strada, Roberto M. Lemoli, Rosa Mangerini, Elisa Coviello, Paolo Carlier, Paola Contini, Annalisa Kunkl, A Bo, Elisabetta Tedone
Publikováno v:
Publons
Web of Science
Web of Science
BACKROUND Hodgkin lymphoma (HL) is a lymphoid malignancy of B-cell origin with a high long-term survival. Despite the efficacy of frontline therapy, about 30% of patient will show relapse or refractory disease (R/R). In this patient population, the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1483ca9e474902ed9e01fc2c624d824f
http://hdl.handle.net/11567/941938
http://hdl.handle.net/11567/941938
Autor:
Elisabetta Tedone, M.C. De Luigi, A Bo, Alberto Serio, M.R. Ruzzenenti, Annalisa Kunkl, Roberto M. Lemoli, Filippo Antonio Canale, Elisa Coviello, Lorenzo Manconi, S. Lucchetti, Filippo Ballerini, Jean Louis Ravetti, Paola Minetto, Fabio Guolo, P. Carlier, Paolo Strada, Emanuela Marcenaro, Rosa Mangerini, Marco Gobbi, Michela Frello, Daniela Fenoglio, Paola Contini
Publikováno v:
HemaSphere. 3:708-709
Autor:
Livia Giannoni, Giordana Pastori, Marino Clavio, Roberto M. Lemoli, Paola Minetto, Daniela Guardo, Annalisa Kunkl, Nicoletta Colombo, Fabio Guolo, Elisa Coviello, Raffaella Grasso, Maurizio Miglino, Filippo Ballerini, Federica Galaverna, Marco Gobbi
Publikováno v:
Blood. 126:4908-4908
BACKGROUND AND AIMS The prognosis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patients has improved since the introduction of tyrosine kinase inhibitors (TKI). The inclusion of TKIs in standard ALL protocols allows a great incre
Autor:
Maurizio Miglino, Guardo Daniela, Marino Clavio, Giulia Rivoli, Filippo Ballerini, Nicoletta Colombo, Marco Gobbi, Roberto M. Lemoli, Elisa Coviello, Raffaella Grasso, Livia Giannoni, Giordana Pastori, Paola Minetto, Fabio Guolo
Publikováno v:
Blood. 126:2601-2601
BACKGROUND AND AIMS Non high risk acute promyelocytic leukemia (APL) patients, as defined by WBC count at diagnosis, have nowadays a very good prognosis when treated with ATRA plus chemotherapy based protocols, with high rate of complete molecular re